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Venous outflow obstruction: An underestimated
contributor to chronic venous disease
Peter Negle´n, MD, PhD, Tara L. Thrasher, BS, and Seshadri Raju, MD, Jackson, Miss
Objective: To assess the importance of iliac venous outflow obstruction in limbs with and without concomitant deep or
superficial reflux, we performed a retrospective analysis of data contemporaneously entered into a set time-stamped
electronic medical records program.
Material and method: Four hundred forty-seven limbs underwent iliac vein stenting of chronic, nonmalignant obstruction
when greater than 50% morphologic stenosis was found at transfemoral venography or intravascular ultrasonography.
Group 1 (female-male ratio, 3.4:1; left limb–right limb, 2.7:1; nonthrombotic-thrombotic, 1.8:1) included 187 stented
limbs in 176 patients with absence of deep and superficial reflux as identified at erect duplex Doppler scanning. Group 2
(female-male, 1.7:1; left-right, 1.9:1, nonthrombotic-thrombotic limb, 1:2.1) included 260 limbs in 253 patients with
combination obstruction and reflux. Reflux was left untreated during the observation period. Clinical outcome (ulcer
healing and recurrence rate, degree of pain per visual analog scale, swelling grade) and hemodynamic effects (ambulatory
venous pressure, venous refilling time, venous filling index at 90 seconds) of iliac venous stenting were assessed.
Result: Patients with reflux and obstruction had more severe disease (clinical class 4-6, 53% in group 2 vs 24% in group
1; P < .001). Similarly, rate of active ulcer was low in limbs with obstruction only (3% vs 24%, groups 1 and 2,
respectively). Mean clinical follow-up was 13  12 months (SD) in 86% of limbs. Because of the presence of reflux in
group 2, venous pressure was higher, venous filling time was shorter, and venous filling index at 90 seconds increased,
compared with group 1. Multisegment scores were 2.6  1.6 and 0, respectively. Of greater interest, there was no
deterioration in venous hemodynamics in group 2 after stenting. There was substantial clinical improvement in both
groups after stenting. Approximately half of patients were completely relieved of pain after stenting, and a third were
completely relieved of swelling. In addition, 55% of ulcerated limbs healed.
Conclusion: Iliac venous outflow obstruction appears to have an important role in clinical expression of chronic venous
insufficiency, particularly in producing pain, and is easily overlooked, mainly because of diagnostic difficulty. The
combination of reflux and obstruction is seen more frequently with severe clinical disease than is obstruction alone. Ulcer
prevalence is clearly associated with reflux, with a low incidence in patients with obstruction alone. Removal of iliac vein
outflow obstruction does not result in increased axial reflux, with clinical deterioration in limbs with combined reflux and
obstruction. (J Vasc Surg 2003;38:879-85.)
Treatment of chronic venous disease has been focused
mainly on controlling axial deep or superficial reflux caused
by incompetent valves. The pathophysiology of chronic
venous disease is complex, and many aspects, such as ob-
struction to outflow, poor calf muscle pump, low venous
compliance, and geometric changes in flow channels, have
largely been ignored, in part because of lack of means to
properly assess the importance of these components and
their specific contribution to the disease. At venous ultra-
sonography, a morphologic obstructive component is pre-
dominant in approximately one third of post-thrombotic
limbs. Obstruction is found in combination with reflux in
55% of symptomatic limbs.1,2 The combination of reflux
and obstruction results in more symptoms and higher
venous ambulatory pressure than either entity alone.3,4
Despite this observation, the fear persists that relief of
proximal blockage will increase distal reflux; that is, it is
thought that proximal obstruction is in some way protec-
tive. No accurate noninvasive or invasive test is available for
evaluation of the hemodynamic significance of venous out-
flow obstruction.5-7 In fact, the degree at which venous
stenosis should be considered hemodynamically “critical”
is unknown. Despite these shortfalls, venous stenting of
iliac vein obstruction on the basis of degree of morphologic
obstruction is beneficial.7-11
The purpose of this study was to assess the importance
of venous outflow obstruction by evaluating clinical out-
come and hemodynamic effect of iliac venous stenting in
limbs with and without concomitant axial deep or superfi-
cial reflux.
MATERIAL AND METHOD
Between October 1996 and August 2002 at our insti-
tution, balloon angioplasty and stenting of the venous
outflow tract—that is, common femoral vein, external and
common iliac veins, or inferior vena cava—were performed
in 613 limbs. During this time, approximately 2621 new
patients were examined for venous disease. Considering an
additional number of stented limbs in existing, reexamined
patients, the rate of venous stenting was approximately 20%
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in our patient population with venous disease, and was
performed in approximately 25% of venous surgeries (613
of 2381).
Two groups of limbs stented because of chronic non-
malignant obstruction were identified and analyzed. Group
1 included 187 stented limbs in 176 patients with absence
of deep and superficial reflux as identified at erect duplex
Doppler scanning. Group 2 comprised 260 limbs in 253
patients with a combination of obstruction and reflux diag-
nosed before stenting. Only outflow blockage was treated
in these limbs; reflux was left untreated. No subsequent
reflux surgery was performed during follow-up. The ob-
structive lesion was considered thrombotic if the patient
had a history of previous deep venous thrombosis or if
post-thrombotic changes in the lower extremity were
found on venograms (61% of limbs) or duplex ultrasound
scans (39% of limbs). Prevalence of thrombotic disease was
54% in the study population.
Group characteristics are shown in Table I. Median age
was slightly higher in patients with combined obstruction
and reflux (group 2), and female-male ratio was higher in
patients with an isolated iliofemoral outflow obstruction
(group 1). Patients in group 1 had more frequent involve-
ment of the left leg compared with patients in group 2.
Conversely, thrombotic obstruction was significantly more
frequent in limbs with reflux (67% vs 36% in groups 2 and 1,
respectively; P  .000). Clinical class of disease (CEAP
classification according to the Reporting Standards of the
International Society for Cardiovascular Surgery and the
Society for Vascular Surgery) is shown in Table II.12 Pa-
tients with reflux and obstruction had more severe clinical
findings of chronic venous disease than did patients with
obstruction only (clinical grade 4-6, 53% vs 24% in group 2
and group 1, respectively; P  .000). Consequently, the
primary complaint of swelling was more often seen in group
1 (68% vs 42%, groups 1 and 2, respectively; P  .000).
Similarly, the rate of active ulcer was low in limbs with
obstruction only (3%) compared with limbs with combined
obstruction and reflux (24%).
Median duration of nonhealing ulcer before stenting
was 14 months (range, 1-102 months), and for all com-
plaints was 15 months (range, 1 month–30 years). Half of
patients (51%) wore compression stockings regularly before
intervention. Preoperative ulcer care and compression ther-
apy continued postoperatively until healing of the ulcer.
The technical details of percutaneous stenting of the
iliofemoral venous outflow tract have been outlined.7-11
The indication for stenting was the finding of more than
50% morphologic stenosis at transfemoral venography or
intravascular ultrasonography. Crosscut area of the stenosis
was measured at intravascular ultrasonography and com-
pared with the area of the normal vein below the stenosis.
The presence of collateral vessels was noted on venograms
before and after stenting. Air plethysmography (APG-
1000; ACI Medical, Sun Valley, Calif), duplex Doppler
scanning with standardized compression, and ascending
and transfemoral venography were performed, and arm-
foot pressure differential, dorsal foot venous hyperemia
pressure, and ambulatory dorsal foot venous pressure were
measured before intervention. Venous function studies
were repeated at follow-up. The methods used have been
described.13-15 Before and after stenting, ambulatory ve-
nous pressure with venous refilling time was determined in
79% (351 of 447) and 35% (155 of 447) of all studied
limbs, respectively; venous filling index in 89% (399 of 447)
and 41% (182 of 447), respectively; and grade of obstruc-
Table I. Characteristics of patients with obstruction only (group 1) compared with patients with combined obstruction
and reflux (group 2)
Obstruction only
(N  176)
Obstruction plus reflux
(N  253)
Pn Range n Range
Median age (y) 49 15-78 52 14-87 .017
Female/male ratio 3.4/1 136/40 1.7/1 160/93 .001
Left limb/right limb ratio 2.7/1 136/51 1.9/1 169/91 .104
Limb nonthrombotic/thrombotic cause 1.8/1 120/67 1/2.1 84/176 .000
Table II. Clinical CEAP class for limbs with obstruction only (group 1) compared with limbs with combined
obstruction and reflux (group 2)
Clinical
class
Obstruction only
(N  187)
Obstruction plus reflux
(N  260)
Pn % Pain (%) n % Pain (%)
2 15 8 100 14 5 100 .357
3 128 68 77 110 42 75 .000
4 37 20 85 56 22 84 .740
5 2 1 100 19 7 89 .004
6 5 3 100 61 24 77 .000
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tion in 78% (347 of 447) and 34% (156 of 447), respec-
tively.
The stented limb was followed up clinically. The study
end point of legs with stasis ulceration was healing, that is,
complete epithelialization. Any breakdown of the ulcer
after healing was considered a recurrence. Degree of pain
was evaluated with a visual analog scale of 0 to 10, with 10
indicative of the most severe pain.16 Swelling was assessed
as grade 0, absent; grade 1, pitting, not obvious; grade 2,
visible ankle edema; and grade 3, massive, encompassing
the entire leg. A single-plane transfemoral venogram was
obtained early (2-3 months) after stenting, again 9 months
later, and annually thereafter for routine surveillance. If the
patient returned with recurrence of symptoms, transfemo-
ral venography was always performed to assess patency of
the venous outflow tract. In-stent recurrent stenosis, if
present, was assessed as percentage diameter reduction of
patent lumen of the stent as observed on the venogram.
Clinical data were entered prospectively into a time-
stamped electronic medical records program for retrospec-
tive analysis. Nonparametric Wilcoxon rank test for paired
and unpaired data and 2 analysis were used for statistical
analysis, as appropriate. Commercially available statistical
programs (GraphPad Prism for Windows, version 3.0, and
GraphPad StatMate, version 1.01i; GraphPad Software,
San Diego, Calif) were used for analysis and power calcu-
lation. P  .05 was considered significant.
RESULTS
Intraoperative observations and procedure out-
come. Intravascular ultrasonography, performed in 402
limbs, revealed greater than 70% stenosis in 72% of limbs
and 50% to 70% stenosis in the remaining limbs. Intraop-
erative venograms obtained before stenting demonstrated
collateral vessels in 66% (287 of 434) of limbs. After stent-
ing, the collateral vessels disappeared completely in 60%
(116 of 287) of limbs and decreased substantially in 21%
(59 of 287) of limbs. There was no mortality and low
nonthrombotic complication rate after venous stenting.
Retroperitoneal hematoma requiring blood transfusion,
and deep venous thrombosis in the contralateral leg devel-
oped in one patient each; and in one patient the guide wire
was caught in the stent, and was removed through a small
groin incision. No late nonthrombotic complications
occurred.
Transfemoral venography was performed in 266 of 447
limbs during follow-up. Thirteen stented veins became
occluded, four early (30 days postoperatively) and nine
late (2-15 months after stenting). In-stent recurrent steno-
sis greater than 50% was noted in 11 stented limbs. Repeat
dilation was successful in 6 limbs, and no additional inter-
vention was performed in 5 limbs. Typically, patients with
symptom relief after stenting had symptom recurrence
when the stent became occluded or significantly narrowed.
No patient had worse symptoms after stenting than before
stenting.
Clinical outcome. Mean clinical follow-up was 13 
12 (SD) months (range, 1-66 months) in 172 of 187 (92%)
limbs with obstruction only and 214 of 260 (82%) limbs
with combined obstruction and reflux. Clinical results (de-
gree of pain and swelling) are shown in Table III. There was
substantial, statistically significant improvement in both
groups after stenting. Improvement in pain relief was most
impressive, with 73% and 70% of patients completely free of
pain after stenting, compared with 24% and 23% before
stenting, in groups 1 and 2, respectively. Improvement in
pain and swelling was similar in both groups. Complete
relief of pain and swelling was observed in one half and
one third of the limbs, respectively, after venous
stenting.
Few patients in group 1 had a history of ulcer (7 limbs,
5 with active ulcer). Three limbs with active ulcer were
followed up, and healed. One of 2 limbs with healed ulcer
demonstrated ulcer recurrence during follow-up. In group
2, 41 of 61 limbs with active ulcers were observed over 15
 14 months (range, 1-53 months) after stenting. About
half (51%) healed and remained healed during this period,
and half (49%) did not heal. Of this latter group, 9 re-
mained virtually unchanged, whereas 11 improved but
never healed completely.
Hemodynamic outcome. Hemodynamic findings in
obstructive limbs with and without reflux before and after
stenting are shown in Table IV. Various hemodynamic
investigations after stenting were performed in 35% to 51%
of limbs with test results available before stenting. The
power to show a change greater than 8% decrease in ambu-
Table III. Clinical result of degree of pain (visual analog scale, 0-10) and swelling (grade 0-3) before and after stenting
in limbs with obstruction only (group 1) and combined obstruction and reflux (group 2)
Obstruction only Obstruction plus reflux
Pre-stent Poststent Pre-stent Poststent
Pain No. of limbs 177 152 244 196
Prevalence (n; %) 135 (76) 41 (27) 186 (77) 58 (30)
Score (median; range) 4 (0-9) 0 (0-9)* 4 (0-9) 0 (0-9)*
Swelling No. of limbs 187 152 249 200
Prevalence (n; %) 170 (91) 91 (60) 207 (83) 94 (47)
Grade (median; range) 2 (0-3) 1 (0-3)* 1 (0-3) 0 (0-3)*
*P  .001.
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latory pressure and greater than 0.3 mL/s change in venous
filling index was 85% to 100%. This indicates that the
sample size was large enough to ensure adequate statistical
comparison. As expected, there were clear between-group
differences before stenting. Because of the presence of
reflux in limbs in group 2, venous pressure was higher,
venous filling time was shorter, and venous filling index at
90 seconds increased in this group, compared with group 1.
Isolated deep and superficial reflux was observed in 37%
and 23% of limbs, respectively. A combination of reflux in
both systems was noted in the remaining 40% of limbs. The
multisegment score was 2.6  1.6 (SD) and 0 in groups 2
and 1, respectively. The maximum multisegment score is 7
(1 point each for incompetence of superficial femoral,
profunda, popliteal, posterior tibial, long and short saphe-
nous, and perforator veins). Of greater interest was that
there was no deterioration in reflux parameters (venous
filling time, venous filling index) or change in ambulatory
venous pressure after stenting in group 2. There was no
difference in degree of obstruction, per Raju test,17 be-
tween the two groups before stenting, and neither group
showed improvement in mean obstruction grade after in-
sertion of the stent.
Positive Raju test results (obstruction grade 2) were
seen before stenting in 27% and 38% of patients in groups 1
and 2, respectively (P .046). Limbs with obstruction grade
2 did not behave differently from those with lower obstruction
grades with regard to clinical response. Ambulatory venous
pressure was not affected in either group after stenting (Table
V). A small but statistically significant decrease in mean hand-
foot pressure differential and obstruction grade was observed
between limbs in which both pre-stenting and post-stenting
pressure tests were obtained (Table VI).
DISCUSSION
In patients with combined reflux and obstruction, de-
mographic, clinical, and hemodynamic features differed
from those in patients with obstruction alone. Although
severity of obstruction was the same in the two groups, as
measured with current techniques, more than half of limbs
with combined outflow obstruction and reflux had severe
Table V. Comparison between limbs with obstruction grade 2-4 and limbs with no hemodynamic obstruction (grade
0-1) according to Raju test
Obstruction grade 2
P
Obstruction grade 1
PPre-stent Poststent Pre-stent Poststent
AVP (% drop) 59  20
(n  108)
62  20
(n  45)
.4913* 65  18
(n  235)
65  18.59
(n  92)
.7637*
Swelling grade 1.8  1.0
(n  115)
1.0  1.1
(n  88)
.0001* 1.6  1.0
(n  229)
0.9  1.1
(n  192)
.0001*
Pain scale 4.3  2.8
(n  112)
1.8  2.6
(n  91)
.0001* 4.0  2.9
(n  223)
0.89  1.8
(n  183)
.0001*
Ulcer healing 6/13 15/23 .771†
AVP, Ambulatory venous pressure.
*Post-stent vs pre-stent values within same group.
†Group 1 vs group 2.
Table IV. Hemodynamic results before and after stenting in limbs with no reflux* and limbs with combined obstruction
and reflux†
Obstruction only Obstruction plus reflux
Pre-stent n Poststent n Pre-stent n Poststent n
AVP (% drop) 71  17 138 70  15‡ 60 58  19§ 213 57  20‡ 95
Venous filling time
(s)¶
57  35 138 54  34‡ 60 27  29§ 213 26  27‡ 95
Venous filling index
(mL/s)
0.9  0.7 168 1.1  0.8‡ 69 3.0  2.4§ 231 3.3  3.9‡ 113
Obstruction grade,
Raju test
1.4  0.7 139 1.3  0.7‡ 49 1.5  0.8# 208 1.4  0.6‡ 107
AVP, Ambulatory venous pressure, normal value 50% drop.
*Multisegment score, 0; group 1.
†Multisegment score, 2.6  1.6 (SD); group 2.
‡No statistical significance, post-stent vs pre-stent values.
§P  .001 group 2 vs. group 1 before stenting.
Normal, 2 ml/s.
¶Normal, 20 s.
#No statistical significance, group 2 vs group 1 before stenting.
JOURNAL OF VASCULAR SURGERY
November 2003882 Negle´n, Thrasher, and Raju
clinical chronic venous disease, with hyperpigmentation,
lipodermatosclerosis, or healed or active ulcer (C4-6), com-
pared with one fourth of limbs with obstruction alone. This
finding is in agreement with the previous observation that
combined reflux and obstruction are more frequently seen
with severe clinical disease than either entity alone.3,4 Ulcer
prevalence is clearly associated with reflux, with a low rate
of 5% in patients with obstruction alone, compared with
24% in patients with reflux also. It is not understood
whether this is due to reflux per se or to associated hemo-
dynamic deterioration.
Percutaneous iliac venous stenting is a safe and efficient
method to correct pelvic venous outflow obstruction.18
Mortality is null, and morbidity is less than 1%. Similar
results were achieved in this study. After stent placement
only a small number of limbs demonstrated late occlusion.
Development of severe in-stent recurrent stenosis creating
greater than 50% obstruction is infrequent. In this study, 9
stented limbs became occluded, and in 11 greater than 50%
in-stent recurrent stenosis developed during follow-up.
These findings are in line with those of previous reports that
showed cumulative secondary patency rate of 93% at 4
years, and cumulative rate of 85% at 42 months for freedom
from in-stent recurrent stenosis greater than 50%.19 Thus it
appears that balloon venoplasty and stenting of the iliac
vein in limbs with chronic obstruction is a safe, minimally
invasive method with minimal complication rate, no mor-
tality, and acceptable 4-year patency rate. A smaller number
of patients have been followed up for 5 years or longer,
without precipitous deterioration of clinical efficacy and
stent patency.
The clinical results of this study indicate that iliac
venous outflow obstruction is important and that disoblit-
eration alone results in substantial clinical improvement in
most limbs with or without remaining concomitant axial
deep or superficial vein incompetence. Significant femo-
roiliocaval outflow obstruction is probably a commonly
overlooked contributing factor in limbs with chronic ve-
nous disease. It was observed and treated in approximately
23% of our patients during the study, and venous stenting
accounted for 25% of venous surgeries performed at our
institution. Traditionally, diagnosis of venous obstruction
has been made on the basis of outflow plethysmography
and femoral venous pressure measurement with exercise.
Determination of outflow resistance and arm-foot venous
pressure has also been used. None of these tests have
proved adequately accurate in borderline obstruction, and
are flawed by poor sensitivity.5-7 Proximal outflow obstruc-
tion does not influence ambulatory venous pressure,20 and
normal ambulatory venous pressure does not exclude pres-
sure increases in the proximal venous system of the lower
extremity.21,22 Therefore, ambulatory venous pressure is
not a suitable diagnostic tool for detection of obstruction.
In this study, ambulatory venous pressure was not affected
by iliac stenting, even in limbs positive for obstruction
before stenting. Lack of appropriate physiologic tests prob-
ably reflects poor understanding of the underlying patho-
physiologic processes. The degree at which venous stenosis
is hemodynamically “critical” is unknown. Experience from
the arterial system may not be applicable in the venous
system because of several fundamental differences.18 In this
study, detection and treatment of obstruction relied on
significant clinical symptoms and signs, combined with the
finding of more than 50% morphologic stenosis. Intravas-
cular ultrasonography and multiplane transfemoral venog-
raphy remain the methods of choice for visualization of iliac
venous obstruction.23 Greater than 70% stenosis was found
in 72% of limbs with intraoperative intravascular ultra-
sonography. Despite lack of pressure correlations, presence
of physiologic obstruction and its relief after stent place-
ment is strongly suggested by disappearance or substantial
decrease in pre-stenting collateral vessels in 81% of limbs.
The degree of hemodynamic improvement, as measured by
decrease of average hand-foot pressure, although statisti-
cally significant, cannot be used for identification of hemo-
dynamic improvement in individual limbs. A more sensitive
physiologic test to identify venous stenosis in individual
limbs is sorely needed.
Strong evidence of the presence of symptomatic ob-
struction and its relief with stenting is provided by impres-
sive clinical relief of pain and swelling, and high rate of ulcer
healing. Approximately one third of limbs were completely
relieved of swelling objectively after stenting, and signifi-
cant improvement was noted in others. Improvement in
degree of swelling is probably underestimated, because of
poor resolution in the grading system. Considerable de-
crease in gross limb swelling with symptomatic improve-
ment was observed after stenting, but the limbs still had
grade 3 disease. The visual analog scale is valid and recog-
nized as a reliable tool for measurement of pain. Although
certainly not free of placebo effect, the high degree and
consistency of pain improvement and concurrent improve-
ment in objective measurement of swelling and ulcer heal-
ing after stent placement suggest a true therapeutic effect
Table VI. Pre-stent and poststent values for hand-foot pressure differential,* dorsal foot venous hyperemia pressure,†
and obstruction grade (according to Raju) in limbs with tests performed before and after stenting
Pre-stent Poststent P
Hand-foot pressure differential (mm Hg) 1.4  1.7 (n  144) 0.8  1.4 (n  144) .0001
Hyperemia pressure increase (mm Hg) 6.1  5.6 (n  137) 6.3  4.4 (n  137) .5933
Obstruction grade 1.3  1.1 (n  149) 0.9  1.1 (n  149) .001
*Normal, 4 mm Hg.
†Normal, 8 mm Hg.
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rather than placebo effect. This is also supported by the
observation that patients with recurrent obstruction had
recurrence of symptoms after a symptom-free period.
About 50% of patients in both groups had complete relief
from pain after venous stenting. Pain is a frequent symp-
tom, and is poorly represented in the clinical component of
the CEAP classification. Clinical improvement frequently
occurred even when associated reflux was left untreated.
Therefore, obstruction appears to have an important role in
clinical expression of chronic venous insufficiency, particu-
larly in production of pain.
Of interest, half of limbs with active ulcer healed after
iliac vein stent placement alone. Median duration of venous
stasis ulcer disease was 14 months. Most patients had
exhausted conservative treatment, such as ulcer dressings,
compression stockings, and Unna boot application, before
stenting, without healing of the ulcer. The same treatment
continued postoperatively. It is unlikely that continued
treatment alone would lead to ulcer healing without stent-
ing. Why ulcers heal and other symptoms abate after stent
placement alone, despite untreated residual reflux, is un-
known. There was no measurable hemodynamic improve-
ment with present techniques to explain this outcome.
It has been perceived that when proximal outflow
obstruction is relieved, axial retrograde reflux through the
distal incompetent valves increases. However, ambulatory
venous pressure, venous refilling time, and venous filling
index did not worsen after stent insertion in patients with
preoperative reflux. Although reflux remained, symptoms
improved. Thus removal of iliac vein outflow obstruction
did not result in increased axial reflux with clinical deterio-
ration in this patient cohort.
It would be preferable to direct treatment with physi-
ologic testing, but inasmuch as such testing is unavailable,
diagnosis and treatment must be based on morphologic
investigations. Gratifying clinical results, relative simplicity
and minimal invasiveness of stent placement, negligible
morbidity, and improvement in quality of life10 after stent-
ing, in our opinion, justify a more aggressive approach
toward diagnosis and treatment of morphologic iliac ve-
nous outflow obstruction. Duplex Doppler ultrasound
scanning has become the mainstay and often the sole
diagnostic method for chronic venous insufficiency in most
centers. As currently used, however, it is insensitive to the
diagnosis of iliac vein obstruction. Awareness and a high
index of suspicion of iliac venous obstruction, combined
with generous use of transfemoral venography and intra-
vascular ultrasonography, are necessary for detection of
borderline obstruction. The target population includes pa-
tients with clinical features (especially pain) out of propor-
tion to detectable disease, patients with no other detectable
basis for their symptoms, patients with symptoms with
visualized pelvic collateral vessels, and patients with a his-
tory or ultrasound scan or venogram evidence of previous
deep vein thrombosis. Venous stenting is evolving as the
initial procedure of choice for treatment of morphologic
iliac venous obstruction, with or without associated reflux.
Open procedures such as bypass grafting and valve recon-
struction may be considered as second-stage interventions
in patients in whom stenting fails. Stent placement does not
preclude subsequent open surgery. If superficial axial long
saphenous vein reflux is present, percutaneous venous
stenting may be combined with minimally invasive sealing
of that vein with radiofrequency or laser therapy at one
visit.24,25 Any associated deep reflux is ignored pending
clinical response to intervention. Although clinical stage is
more severe with combined reflux and obstruction, correc-
tion of obstruction alone results in substantial clinical im-
provement, even with remaining reflux.
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